Low Testosterone in Elderly Patients: To Treat or Not to Treat?

testosterone, elderly, erectile dysfunction, ED, geriatrics, cardiovascular disease, cancer, vascular insufficiency, antihypertensives, follicle-stimulating hormone, FSH, luteinizing hormone, LH, prolactin, replacement therapy, prostate, prostate cancer, benign prosatic hyperplasia, BPH, cardiovascular risk, Women's Health Initiative, estrogen replacement, urologytestosterone, elderly, erectile dysfunction, ED, geriatrics, cardiovascular disease, cancer, vascular insufficiency, antihypertensives, follicle-stimulating hormone, FSH, luteinizing hormone, LH, prolactin, replacement therapy, prostate, prostate cancer, benign prosatic hyperplasia, BPH, cardiovascular risk, Women's Health Initiative, estrogen replacement, urology

testosterone, elderly, erectile dysfunction, ED, geriatrics, cardiovascular disease, cancer, vascular insufficiency, antihypertensives, follicle-stimulating hormone, FSH, luteinizing hormone, LH, prolactin, replacement therapy, prostate, prostate cancer, benign prosatic hyperplasia, BPH, cardiovascular risk, Women's Health Initiative, estrogen replacement, urologytestosterone, elderly, erectile dysfunction, ED, geriatrics, cardiovascular disease, cancer, vascular insufficiency, antihypertensives, follicle-stimulating hormone, FSH, luteinizing hormone, LH, prolactin, replacement therapy, prostate, prostate cancer, benign prosatic hyperplasia, BPH, cardiovascular risk, Women's Health Initiative, estrogen replacement, urology

testosterone, elderly, erectile dysfunction, ED, geriatrics, cardiovascular disease, cancer, vascular insufficiency, antihypertensives, follicle-stimulating hormone, FSH, luteinizing hormone, LH, prolactin, replacement therapy, prostate, prostate cancer, benign prosatic hyperplasia, BPH, cardiovascular risk, Women's Health Initiative, estrogen replacement, urologytestosterone, elderly, erectile dysfunction, ED, geriatrics, cardiovascular disease, cancer, vascular insufficiency, antihypertensives, follicle-stimulating hormone, FSH, luteinizing hormone, LH, prolactin, replacement therapy, prostate, prostate cancer, benign prosatic hyperplasia, BPH, cardiovascular risk, Women's Health Initiative, estrogen replacement, urology